4//SEC Filing
Eller Mark G. 4
Accession 0001232524-11-000030
CIK 0001232524other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 6:12 PM ET
Size
7.2 KB
Accession
0001232524-11-000030
Insider Transaction Report
Form 4
Eller Mark G.
SVP, Research & Clinical Dev.
Transactions
- Exercise/Conversion
Common Stock
2011-08-13+690→ 4,151 total - Exercise/Conversion
Restricted Stock Units
2011-08-13−690→ 0 total→ Common Stock (690 underlying)
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units into common stock. Such restricted stock units were previously reported in Table II on a Form 3 filed with the Securities and Exchange Commission on February 16, 2011.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock upon the vesting of the unit.
- [F3]100% of the restricted stock units vested on August 13, 2011. The common stock into which such vested restricted stock units converted on August 13, 2011 is reported in Table I on this Form 4.
Documents
Issuer
JAZZ PHARMACEUTICALS INC
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001513026
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 6:12 PM ET
- Size
- 7.2 KB